Search results for "PROGNOSIS"

showing 10 items of 2052 documents

A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, for Control of Graves Hyperthyroidism—A Proof-of-Concept Trial

2019

Abstract Context The CD40-CD154 co-stimulatory pathway plays an important role in the pathogenesis of Graves disease (GD) by promoting autoreactive B-cell activation. Objective Evaluate efficacy and safety of a human, blocking, nondepleting anti-CD40 monoclonal antibody, iscalimab, in hyperthyroid patients with GD. Design Open-label, phase II proof-of-concept study. Setting Multicenter. Patients Fifteen with GD. Intervention Patients received 5 doses of iscalimab at 10 mg/kg intravenously over 12 weeks. Main outcome measures Thyroid-related hormones and autoantibodies, plasma soluble CD40, free CD40 on B cells, soluble CXCL13, pharmacokinetics, and safety were assessed. Results The iscalima…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismGraves' diseasemedicine.medical_treatmentClinical BiochemistryContext (language use)Thyroid Function TestsHyperthyroidismProof of Concept StudyBiochemistryGastroenterologyThyrotropin receptorYoung AdultEndocrinologyThyroid peroxidaseInternal medicinemedicineHumansTissue DistributionCD40 AntigensAdverse effectAgedTriiodothyroninebiologybusiness.industryBiochemistry (medical)AutoantibodyAntibodies MonoclonalMiddle AgedPrognosismedicine.diseaseEndocrinologybiology.proteinFemaleThyroglobulinbusinessFollow-Up StudiesThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Altered glutathione system is associated with the presence of distal symmetric peripheral polyneuropathy in type 2 diabetic subjects.

2015

Abstract Distal symmetric peripheral polyneuropathy (DSPN) is a highly prevalent complication of diabetes. However, underlying pathophysiological mechanisms are multiple and not well understood. The aim of our study was to analyze the oxidative stress levels in circulating mononuclear cells by measuring the glutathione system, malondialdehyde and oxidized-LDL, in 60 type 2 diabetic patients from a well-characterized cohort of 196 type 2 diabetic patients. Using a nested case–control design, we studied 30 type 2 diabetic patients with distal symmetric polyneuropathy and 30 diabetic controls without this complication, according to the Neuropathy Disability Score. We have found that diabetic p…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.disease_causePeripheral blood mononuclear cellRisk AssessmentSeverity of Illness IndexAntioxidantschemistry.chemical_compoundEndocrinologyDiabetic NeuropathiesInternal medicineDiabetes mellitusMalondialdehydeInternal MedicineMedicineHumansAgedChi-Square Distributionbusiness.industryIncidenceType 2 Diabetes MellitusGlutathioneMiddle AgedMalondialdehydemedicine.diseasePrognosisGlutathionePathophysiologyOxidative StressEndocrinologychemistryDiabetes Mellitus Type 2Case-Control StudiesFemalebusinessComplicationOxidative stressJournal of diabetes and its complications
researchProduct

Leisure-time cross-country skiing is associated with lower incidence of type 2 diabetes:A prospective cohort study

2019

Background Cross-country skiing is associated with reduction in risk of adverse vascular outcomes, but its association with type 2 diabetes is uncertain. We aimed to assess the associations between leisure-time cross-country skiing habits and incident type 2 diabetes. Methods We analysed the data of 2483 middle-aged men with no history of diabetes at baseline in the Kuopio Ischemic Heart Disease prospective study. The frequency, average duration, and intensity of leisure cross-country skiing were assessed at baseline using a 12-month physical activity questionnaire. Hazard ratios (HRs) (95% CIs) for type 2 diabetes were estimated. Results During a median follow-up of 21.6 years, 539 men dev…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismphysical activity030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematologyMetabolic equivalent03 medical and health sciencesLeisure Activities0302 clinical medicineEndocrinologySkiingInternal medicineDiabetes mellitusEpidemiologyInternal MedicineHumansMedicineProspective StudiesProspective cohort studyExerciseFinlandbusiness.industryIncidenceHazard ratioMiddle AgedPrognosismedicine.diseaseDiabetes Mellitus Type 2high-intensity exercise trainingFemaletype 2 diabetesbusinessRisk assessmenthuman activitiescross-country skiingFollow-Up StudiesCohort study
researchProduct

NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.

2011

The NOA-05 multicenter trial was performed to analyze the efficacy of primary chemotherapy with procarbazine and lomustine (PC) in patients with gliomatosis cerebri (GC) and to define clinical, imaging, and molecular factors influencing outcome.Thirty-five patients with previously untreated GC were treated with up to six 56-day courses of 110mg/m(2) lomustine on day 1 and 60mg/m(2) procarbazine on days 8 to 21. The primary endpoint was the rate of patients without therapy failure (defined as progressive disease, death from any cause, or termination of PC therapy before the end of course 4) at 8 months after the beginning of PC chemotherapy.The failure-free survival rate at 8 months was 50.3…

AdultMalemedicine.medical_specialtyEndpoint DeterminationGliomatosis cerebriAntineoplastic AgentsGene mutationProcarbazineGastroenterologyDisease-Free SurvivalLomustineInternal medicineMulticenter trialAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumorMedicineHumansProspective StudiesKarnofsky Performance StatusSurvival rateDNA Modification MethylasesAgedbusiness.industryTumor Suppressor ProteinsHazard ratioBrainLomustineMiddle Agedmedicine.diseasePrognosisCombined Modality TherapyMagnetic Resonance ImagingNeoplasms NeuroepithelialSurvival AnalysisSurgeryDNA Repair EnzymesTreatment OutcomeNeurologyProcarbazineSample SizeDisease ProgressionFemaleNeurology (clinical)businessProgressive diseasemedicine.drugAnnals of neurology
researchProduct

Automatic Evaluation of Histological Prognostic Factors Using Two Consecutive Convolutional Neural Networks on Kidney Samples

2022

BACKGROUND AND OBJECTIVES: The prognosis of patients undergoing kidney tumor resection or kidney donation is linked to many histologic criteria. These criteria notably include glomerular density, glomerular volume, vascular luminal stenosis, and severity of interstitial fibrosis/tubular atrophy. Automated measurements through a deep-learning approach could save time and provide more precise data. This work aimed to develop a free tool to automatically obtain kidney histologic prognostic features. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In total, 241 samples of healthy kidney tissue were split into three independent cohorts. The “Training” cohort (n=65) was used to train two convoluti…

AdultMalemedicine.medical_specialtyEpidemiologyTubular atrophyUrologyKidneyCritical Care and Intensive Care MedicineConvolutional neural networkCortex (anatomy)medicineHumansAgedTransplantationKidneybusiness.industryDeep learningArea under the curveMiddle AgedPrognosismedicine.diseaseKidney NeoplasmsStenosismedicine.anatomical_structureNephrologyCohortOriginal ArticleFemaleNeural Networks ComputerArtificial intelligencebusinessClinical Journal of the American Society of Nephrology
researchProduct

Clinical and epidemiological characteristics of pyogenic liver abscess in people 65 years or older versus people under 65: a retrospective study

2017

Abstract Background To analyse the clinical, epidemiological, microbiological and prognostic differences of pyogenic liver abscess (PLA) in older (≥ 65 years of age) versus younger patients (< 65 years). Methods Multicentre, retrospective cohort study in all patients with PLA admitted to two Spanish hospitals from January 2000 to January 2014. Cases were divided into two age groups (< 65 years and ≥65 years) for comparison of clinical, epidemiological and microbiological characteristics as well as treatment. Results Of 98 patients analysed, 40 patients were younger than 65, and 58 were aged 65 or older. Significant associations in the older group were found with female sex (adjusted odds ra…

AdultMalemedicine.medical_specialtyEpidemiologylcsh:GeriatricsChronic liver diseaseMicrobiologyBiliary diseaseCohort Studies03 medical and health sciencesYoung Adult0302 clinical medicineInternal medicineEpidemiologymedicineEscherichia coliHumansMortalityEscherichia coli InfectionsAgedRetrospective StudiesPyogenic liver abscessAged 80 and overbusiness.industryIncidence (epidemiology)IncidenceAge FactorsRetrospective cohort studyOdds ratioPyogenicMiddle Agedmedicine.diseasePrognosisSurgeryLiver abscesslcsh:RC952-954.6Liver Abscess Pyogenic030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemaleGeriatrics and GerontologybusinessLiver abscessResearch ArticleBMC Geriatrics
researchProduct

A multiple biomarker risk score for guiding clinical decisions using a decision curve approach.

2011

Aims: We assessed whether a cardiovascular risk model based on classic risk factors (e.g. cholesterol, blood pressure) could refine disease prediction if it included novel biomarkers (C-reactive protein, N-terminal pro-B-type natriuretic peptide, troponin I) using a decision curve approach which can incorporate clinical consequences. Methods and results: We evaluated whether a model including biomarkers and classic risk factors could improve prediction of 10 year risk of cardiovascular disease (CVD; chronic heart disease and ischaemic stroke) against a classic risk factor model using a decision curve approach in two prospective MORGAM cohorts. This included 7739 men and women with 457 CVD …

AdultMalemedicine.medical_specialtyEpidemiologymedicine.drug_classBlood PressureDiseaseRisk AssessmentDecision Support TechniquesSex FactorsPredictive Value of TestsRisk FactorsInternal medicineTroponin INatriuretic Peptide BrainmedicineNatriuretic peptideHumansRisk thresholdProspective StudiesFramingham Risk Scorebusiness.industryTroponin IAge FactorsMiddle AgedPrognosisPeptide FragmentsSurgeryEuropeBlood pressureC-Reactive ProteinCholesterolCardiovascular DiseasesCohortBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersEuropean journal of preventive cardiology
researchProduct

Clinicopathological characteristics of Epstein-Barr virus-positive gastric cancer in Latvia

2019

Objective Epstein-Barr virus (EBV)-associated gastric cancer has been proposed to be a distinct gastric cancer molecular subtype. The prognostic significance of EBV infection in gastric cancer remains unclear and needs further investigation. Our study aimed to analyze EBV-positive and EBV-negative gastric cancer patients regarding their personal and tumor-related characteristics, and compare their overall survival. Methods Gastric cancer patients consecutively treated at the Riga East University Hospital during 2009-2016 were identified retrospectively. Tumor EBV status was determined by in-situ hybridization for EBV-encoded RNA (EBER). Information about clinicopathological characteristics …

AdultMalemedicine.medical_specialtyEpstein-Barr Virus InfectionsComorbidityKaplan-Meier EstimateAdenocarcinomaGastroenterologyHospital recordsArticle03 medical and health sciencesYoung Adult0302 clinical medicineAge DistributionStomach NeoplasmsInternal medicinehemic and lymphatic diseasesmedicineHumansStage (cooking)Sex DistributionAgedNeoplasm StagingProportional Hazards ModelsRetrospective StudiesAged 80 and overHepatologyStage I Gastric Cancerbusiness.industryHazard ratioSmokingGastroenterologyCancerEpstein-Barr Virus PositiveMiddle AgedOverweightUniversity hospitalmedicine.diseasePrognosisLatviaConfidence intervalSurvival Rate030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemaleNeoplasm Gradingbusiness
researchProduct

Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and ade…

2006

AIM: C-reactive protein (CRP) is an acute-phase reactant and a known indicator of the malignant potential of the tumour. The aim of this study was to investigate the significance of preoperative CRP as a parameter of the perioperative course and long-term prognosis in patients with squamous cell carcinoma and adenocarcinoma of the oesophagus. METHODS: Serum CRP was determined preoperatively in 291 of 371 patients undergoing oesophagectomy for cancer from December 1989 to March 2004. Median patient age was 59 (28-79) year, 82.5% of patients were males. Squamous cell carcinoma was diagnosed in 151 (51.9%) and adenocarcinoma in 122 patients. Transhiatal oesophagectomy was done in 151 (51.9%) p…

AdultMalemedicine.medical_specialtyEsophageal NeoplasmsAdenocarcinomaSeverity of Illness IndexGastroenterologyPerioperative CarePredictive Value of TestsInternal medicineBiomarkers TumorOdds RatiomedicineHumansSurvival rateAgedNeoplasm Stagingbiologybusiness.industryC-reactive proteinHazard ratioGastroenterologyCancerGeneral MedicinePerioperativeOdds ratioMiddle AgedPrognosismedicine.diseaseSurgeryC-Reactive ProteinPredictive value of testsMultivariate AnalysisCarcinoma Squamous CellDisease Progressionbiology.proteinAdenocarcinomaFemalebusinessRapid CommunicationFollow-Up StudiesWorld Journal of Gastroenterology
researchProduct

Baseline characteristics and outcome in Romanian patients with Gaucher disease type 1.

2009

Abstract Background/aim To present clinical and genetic characteristics of all Romanian patients with Gaucher disease type 1, in whom specific diagnosis has been confirmed by enzymatic and molecular methods and to analyze their outcome with and without enzymatic replacement therapy (ERT). Patients, methods There are fifty patients (F/M — 1.63/1) with Gaucher disease type 1. Clinical status, haemoglobin, thrombocytes, hepatic/splenic volume, bone mineral density and severity score were assessed at baseline and every six months thereafter. Thirty-nine patients (78%) received imiglucerase (44.4 ± 13.6 U/kg/2 weeks) for 3.1 +/− 1.4 years. Results Based on general prevalence data, our group repr…

AdultMalemedicine.medical_specialtyEvery Six MonthsBone diseaseImigluceraseAdolescentGenotypeDiseaseGastroenterologyYoung AdultInternal medicineGenotypeInternal MedicinemedicineHumansPlateletAge of OnsetChildAllelesBone mineralGaucher Diseasebusiness.industryRomaniaInfantAnemiaMiddle Agedmedicine.diseasePrognosisThrombocytopeniaSurgeryHexosaminidasesChild PreschoolMutationSplenomegalyGlucosylceramidaseFemalebusinessVisceromegalymedicine.drugEuropean journal of internal medicine
researchProduct